Found 88 matching trials
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer PHASE2 The researchers are doing this study to find out if stereotactic body radia...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Learn More & Join Trial
Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer NA The LDR BURST trial will compare the side effects of two radiotherapy treat...
Show More Location
Royal Surrey NHS Foundation Trust
Learn More & Join Trial
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer PHASE2 Pancreatic cancer, most commonly adenocarcinoma, is the fourth leading caus...
Show More Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Learn More & Join Trial
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers NA After surgery to remove the main endometrial and/or cervical tumor, most wo...
Show More Location
University of California at Los Angeles
Learn More & Join Trial
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer PHASE2 For this study, unfavorable intermediate risk prostate cancer patients will...
Show More Location
NYU Langone Health
Learn More & Join Trial
Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer N/A The purpose of this study is to development of more effective treatment tac...
Show More Location
National Center of Oncology
Learn More & Join Trial
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N NA To derive the maximum tolerated dose of hypofractionated stereotactic body ...
Show More Location
Radiotherapy department, University Hospital Ghent
Learn More & Join Trial
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer PHASE2 The hypo-FLAME study is a multicenter phase II study (n=100) to investigate...
Show More Learn More & Join Trial
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers PHASE1 This phase I trial studies how well stereotactic body radiation therapy wor...
Show More Location
UT Southwestern/Simmons Cancer Center-Dallas
Learn More & Join Trial
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) PHASE1 The study is an open-label phase I/II clinical trial. The study will enroll...
Show More Location
Washington University School of Medicine
Learn More & Join Trial